November 2025

"Kia ora" from New Zealand

50+

Completed Trials

200+

Participants

We are pleased to announce that ethics approval for the
ROADMAP study in New Zealand was successfully obtained
in June 2025!

This milestone marks the beginning of an important new
phase as we activate sites across the country.
‍
The ROADMAP database is currently being adapted to ensure that consent and data collection procedures align with the New Zealand requirements.
‍
Georgia Fowler, our Lead NZ ROADMAP coordinator, has been hard at work organising all the trial-related documentation and supporting sites through their activ tion proce ses, and ROADMAP investigator Dr. John Mutu-Grigg (Ngati Kahu, Te Rarawa) has outlined the additional support he will provide to Maori partidpants on their ROADMAP journey.

Congratulations to Waitemata for becoming the first site to be activated in New Zealand - a fantastic achievement and an encouraging sign of the momentum building around the trial. Meanwhile, Middlemore Hospital is preparing for its upcoming site initiation visit, and Auckland is also planning theirs soon. Tauranga and Christchurch are actively working through the necessary local! approvals to join the ROADMAP study. With these sites coming on board, we are hopeful to recruit our first New Zealand participant before he end
of the year. Watch this space!

April/May 2026

NEW ZEALAND

50+

Completed Trials

200+

Participants

The ROADMAP trial is gaining great momentum across Aotearoa, with steady progress on recruitment and site activity.
‍
Three New Zealand sites are now fully open and recruiting (Te Toka Tumai (Auckland), Counties Manukau (Middlemore), and Waitematā (North Shore). Tauranga is preparing for a site initiation visit, which will further expand our national footprint and capacity, and Christchurch is close behind.
‍
Recruitment is well underway, with 22 participants enrolled into the ROADMAP platform and 34 participants in the ROADMAP registry nationwide. Congratulations Waitematā (North Shore) Hospital!
‍
Waitematā became the first site to enrol a participant in all three treatment domains, earning themselves a well-deserved cookie cake to celebrate this milestone!

A warm thank you to all site teams for your continued mahi in supporting participants and keeping the trial moving forward.

In addition, we are pleased to share that a new one-page flyer has recently been approved by the national ethics body (HDEC). This resource is designed to help support recruitment conversations with potential ROADMAP participants. We hope this tool will further strengthen our recruitment efforts across all sites.

Hei kona mai (goodbye for now),
Team New Zealand